C07D 471/10
Spiro-condensed systems
C07D471/10 (Spiro-condensed systems) appears on 1,818 US grants and 2,436 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,818
- Published applications
- 2,436
- Assignees
- 860
- Inventors
- 7,204
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 2 | 0 |
| 1978 | 6 | 0 |
| 1979 | 1 | 0 |
| 1980 | 11 | 0 |
| 1981 | 10 | 0 |
| 1982 | 5 | 0 |
| 1983 | 11 | 0 |
| 1984 | 3 | 0 |
| 1985 | 7 | 0 |
| 1986 | 5 | 0 |
| 1987 | 8 | 0 |
| 1988 | 9 | 0 |
| 1989 | 4 | 0 |
| 1990 | 13 | 0 |
| 1991 | 20 | 0 |
| 1992 | 18 | 0 |
| 1993 | 12 | 0 |
| 1994 | 7 | 0 |
| 1995 | 9 | 0 |
| 1996 | 7 | 0 |
| 1997 | 22 | 0 |
| 1998 | 20 | 0 |
| 1999 | 18 | 0 |
| 2000 | 17 | 0 |
| 2001 | 29 | 8 |
| 2002 | 28 | 22 |
| 2003 | 25 | 39 |
| 2004 | 20 | 63 |
| 2005 | 26 | 61 |
| 2006 | 31 | 58 |
| 2007 | 37 | 69 |
| 2008 | 27 | 77 |
| 2009 | 44 | 90 |
| 2010 | 51 | 87 |
| 2011 | 51 | 83 |
| 2012 | 79 | 90 |
| 2013 | 88 | 97 |
| 2014 | 94 | 100 |
| 2015 | 91 | 113 |
| 2016 | 82 | 96 |
| 2017 | 89 | 100 |
| 2018 | 87 | 112 |
| 2019 | 90 | 111 |
| 2020 | 74 | 107 |
| 2021 | 91 | 113 |
| 2022 | 71 | 126 |
| 2023 | 57 | 164 |
| 2024 | 72 | 173 |
| 2025 | 87 | 157 |
| 2026 | 48 | 120 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Orexin receptor agonists and uses thereof29 Sep 2026US 12,747,252 B2Jazz Pharmaceuticals Ireland Limited
- Colored fiber, method for manufacturing colored fiber, and fiber product29 Sep 2026US 12,747,518 B2Kaneka Corporation
- Antimicrobial compounds and methods28 Jul 2026US 12,692,253 B2Curza Global, LLC
- Aminopyrimidine compound as CDK2/4/6 triple inhibitor14 Jul 2026US 12,679,837 B2Cisen Pharmaceutical Co., Ltd.
- Spiros and related analogs for inhibiting YAP/TAZ-TEAD7 Jul 2026US 12,673,950 B2Katholieke Universiteit Leuven
- Technologies targeting cell states8 Oct 2026US 2026/0306640 A1Auron Therapeutics, Inc.
- Estrogen-receptor modulator and use thereof8 Oct 2026US 2026/0308139 A1Jiangsu Vcare PharmaTech Co., Ltd.
- Salts and polymorphic forms of menin inhibitors and pharmaceutical compositions thereof1 Oct 2026US 2026/0294909 A1Syndax Pharmaceuticals, Inc.
- Biarylamide derivatives and their use as pkmyt1 inhibitors1 Oct 2026US 2026/0297042 A1Cancer Research Technology Limited
- Benzo-fused ring compound inhibitor, and preparation method therefor and use thereof1 Oct 2026US 2026/0297071 A1Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
Most cited
By later US patents
- Modulators of ATP-binding cassette transporters157US 7,495,103 B2Vertex Pharmaceuticals Incorporated · 2009
- Proline derivatives and the use thereof as drugs112US 7,074,794 B2Mitsubishi Pharma Corporation · 2006
- Proline derivatives and use thereof as drugs109US 7,060,722 B2Mitsubishi Pharma Corporation · 2006
- 4-pyrazolyl-N-arylpyrimidin-2-amines and 4-pyrazolyl-N-heteroarylpyrimidin-2-amines as janus kinase inhibitors109US 8,309,718 B2Incyte Corporation · 2012
- Modulators of ATP-binding cassette transporters109US 8,642,609 B2Vertex Pharmaceuticals Incorporated · 2014